Completed
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus
NCT00657189
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- Research Site Anniston, Alabama, United States
- Research Site Huntington Beach, California, United States
- Research Site Upland, California, United States
- Research Site Colorado Springs, Colorado, United States